General MedicationsINJECTIONGeneric
SPECTAMINE
IOFETAMINE HYDROCHLORIDE I-123
Standard Dose
1mCi/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview SPECTAMINE is listed in Drugs@FDA under application 019432 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient IOFETAMINE HYDROCHLORIDE I-123 Form and strength INJECTABLE;INJECTION - 1mCi/ML Sponsor IMP Submission history Latest submission status date: 1988-07-29 00:00:00.
Structured Monograph
Clinical summary
Approval overview SPECTAMINE is listed in Drugs@FDA under application 019432 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient IOFETAMINE HYDROCHLORIDE I-123 Form and strength INJECTABLE;INJECTION - 1mCi/ML Sponsor IMP Submission history Latest submission status date: 1988-07-29 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.